Grown Rogue International Inc. Share Price OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4200 USD | +2.10% |
|
+5.18% | -18.59% |
| 08-05 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| 08-04 | Grown Rogue International Inc., Q2 2026 Earnings Call, Aug 04, 2026 |
| Market Cap | 105M 91.11M 84.93M 78.11M 147M 10B 149M 998M 392M 5B 395M 386M 16.58B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 120M 104M 97.28M 89.47M 169M 11.46B 171M 1.14B 449M 5.73B 453M 443M 18.99B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +2.10% | ||
| 1 week | +5.18% | ||
| Current month | -0.40% | ||
| 1 month | -8.79% | ||
| 3 months | +13.51% | ||
| 6 months | +1.03% | ||
| Current year | -18.59% |
| 1 week | 0.38 |  | 0.44 |
| 1 month | 0.36 | | 0.48 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.17 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 14/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.10% | +5.18% | - | - | 105M | |
| -1.55% | -1.91% | -9.40% | -6.00% | 13.45B | |
| -2.68% | -3.09% | -32.09% | -54.39% | 5.09B | |
| -0.64% | +0.84% | +5.03% | +8.07% | 5.13B | |
| -2.08% | -1.67% | +0.49% | -33.25% | 4.07B | |
| -1.35% | -2.10% | -7.35% | -4.11% | 3.7B | |
| -0.61% | -2.60% | -2.67% | +4.67% | 3.58B | |
| -0.82% | -1.44% | -4.96% | +12.93% | 3.48B | |
| -0.89% | +0.19% | -14.80% | -23.12% | 2.45B | |
| -1.53% | -2.85% | -3.23% | +49.80% | 1.87B | |
| Average | -1.00% | -2.37% | -7.66% | -5.05% | 4.76B | |
| Weighted average by Cap. | -1.42% | -2.67% | -8.37% | -8.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.4M 21.81M 20.06M 37.87M 2.57B 38.3M 256M 101M 1.29B 101M 99.23M 4.26B | 32.43M 28.09M 26.18M 24.08M 45.46M 3.08B 45.97M 308M 121M 1.54B 122M 119M 5.11B |
| Net income | -11.3M -9.79M -9.13M -8.39M -15.85M -1.07B -16.02M -107M -42.09M -538M -42.45M -41.52M -1.78B | 1.73M 1.5M 1.4M 1.28M 2.42M 164M 2.45M 16.41M 6.44M 82.3M 6.5M 6.35M 273M |
| Net Debt | 3.7M 3.21M 2.99M 2.75M 5.19M 352M 5.25M 35.14M 13.79M 176M 13.91M 13.61M 584M | 15.3M 13.25M 12.35M 11.36M 21.45M 1.45B 21.69M 145M 56.97M 728M 57.46M 56.19M 2.41B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | US$0.4200 | +2.10% | 175,050 |
| 04/08/26 | US$0.4114 | +6.68% | 51,217 |
| 03/08/26 | US$0.3856 | -8.56% | 7,387 |
| 31/07/26 | US$0.4217 | +2.85% | 192,164 |
| 30/07/26 | US$0.4100 | +2.68% | 341,619 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUSF Stock
Select your edition
All financial news and data tailored to specific country editions
